Comparison of switch therapy modalities (enoxaparine to rivaroxaban or dabigatran) with enoxaparine alone after hip and knee replacement; a non-blinded, randomised study | Zendy

Turhan Özler | Zendy

Open Access

Comparison of switch therapy modalities (enoxaparine to rivaroxaban or dabigatran) with enoxaparine alone after hip and knee replacement; a non-blinded, randomised study

Author(s) -

Turhan Özler

Publication year - 2015

Publication title -

acta orthopaedica et traumatologica turcica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.586

H-Index - 28

eISSN - 2589-1294

pISSN - 1017-995X

DOI - 10.3944/aott.2015.14.0219

Subject(s) - medicine , dabigatran , rivaroxaban , venous thrombosis , surgery , pulmonary embolism , randomized controlled trial , anesthesia , thrombosis , warfarin , atrial fibrillation

Prevention of deep venous thrombosis (DVT) and associated pulmonary embolism following major orthopedic surgeries is challenging, and there is an increased interest in developing new treatment strategies. We compared 2 switch-therapy modalities-enoxaparin to rivaroxaban and enoxaparin to dabigatran-and enoxaparin monotherapy for preventing DVT after total knee arthroplasty (TKA) and total hip arthroplasty (THA).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research